|
Volumn 23, Issue 12, 2004, Pages 1700-1703
|
Short-term efficacy of combined chemotherapy of gemcitabine and cisplatin on advanced hormone refractory prostate cancer.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
RIBONUCLEOTIDE REDUCTASE;
ADJUVANT CHEMOTHERAPY;
AGED;
ARTICLE;
BONE TUMOR;
CANCER STAGING;
CASTRATION;
DRUG ANTAGONISM;
FOLLOW UP;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PROSTATE TUMOR;
SURVIVAL RATE;
AGED;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CASTRATION;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DEOXYCYTIDINE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROSTATIC NEOPLASMS;
RIBONUCLEOTIDE REDUCTASES;
SURVIVAL RATE;
|
EID: 28744450993
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|